Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

138 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
PHOX2B is a novel and specific marker for minimal residual disease testing in neuroblastoma.
Stutterheim J, Gerritsen A, Zappeij-Kannegieter L, Kleijn I, Dee R, Hooft L, van Noesel MM, Bierings M, Berthold F, Versteeg R, Caron HN, van der Schoot CE, Tytgat GA. Stutterheim J, et al. Among authors: van noesel mm, van der schoot ce. J Clin Oncol. 2008 Nov 20;26(33):5443-9. doi: 10.1200/JCO.2007.13.6531. Epub 2008 Oct 6. J Clin Oncol. 2008. PMID: 18838715
Detecting minimal residual disease in neuroblastoma: the superiority of a panel of real-time quantitative PCR markers.
Stutterheim J, Gerritsen A, Zappeij-Kannegieter L, Yalcin B, Dee R, van Noesel MM, Berthold F, Versteeg R, Caron HN, van der Schoot CE, Tytgat GA. Stutterheim J, et al. Among authors: van noesel mm, van der schoot ce. Clin Chem. 2009 Jul;55(7):1316-26. doi: 10.1373/clinchem.2008.117945. Epub 2009 May 21. Clin Chem. 2009. PMID: 19460840 Free article.
Improvement of neurological status and quality of life in children with opsoclonus myoclonus syndrome at long-term follow-up.
Catsman-Berrevoets CE, Aarsen FK, van Hemsbergen ML, van Noesel MM, Hakvoort-Cammel FG, van den Heuvel-Eibrink MM. Catsman-Berrevoets CE, et al. Among authors: van den heuvel eibrink mm, van noesel mm, van hemsbergen ml. Pediatr Blood Cancer. 2009 Dec;53(6):1048-53. doi: 10.1002/pbc.22226. Pediatr Blood Cancer. 2009. PMID: 19672966
Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes.
Molenaar JJ, Koster J, Zwijnenburg DA, van Sluis P, Valentijn LJ, van der Ploeg I, Hamdi M, van Nes J, Westerman BA, van Arkel J, Ebus ME, Haneveld F, Lakeman A, Schild L, Molenaar P, Stroeken P, van Noesel MM, Ora I, Santo EE, Caron HN, Westerhout EM, Versteeg R. Molenaar JJ, et al. Among authors: van noesel mm, van nes j, van sluis p, van arkel j, van der ploeg i. Nature. 2012 Feb 22;483(7391):589-93. doi: 10.1038/nature10910. Nature. 2012. PMID: 22367537 Free article.
LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression.
Molenaar JJ, Domingo-Fernández R, Ebus ME, Lindner S, Koster J, Drabek K, Mestdagh P, van Sluis P, Valentijn LJ, van Nes J, Broekmans M, Haneveld F, Volckmann R, Bray I, Heukamp L, Sprüssel A, Thor T, Kieckbusch K, Klein-Hitpass L, Fischer M, Vandesompele J, Schramm A, van Noesel MM, Varesio L, Speleman F, Eggert A, Stallings RL, Caron HN, Versteeg R, Schulte JH. Molenaar JJ, et al. Among authors: van noesel mm, van nes j, van sluis p. Nat Genet. 2012 Nov;44(11):1199-206. doi: 10.1038/ng.2436. Epub 2012 Oct 7. Nat Genet. 2012. PMID: 23042116
MIBG scans in patients with stage 4 neuroblastoma reveal two metastatic patterns, one is associated with MYCN amplification and in MYCN-amplified tumours correlates with a better prognosis.
Bleeker G, van Eck-Smit BL, Zwinderman KH, Versteeg R, van Noesel MM, Kam BL, Kaspers GJ, van Schie A, Kreissman SG, Yanik G, Hero B, Schmidt M, Laureys G, Lambert B, Øra I, Schulte JH, Caron HN, Tytgat GA. Bleeker G, et al. Among authors: van noesel mm, van schie a, van eck smit bl. Eur J Nucl Med Mol Imaging. 2015 Feb;42(2):222-30. doi: 10.1007/s00259-014-2909-1. Epub 2014 Sep 30. Eur J Nucl Med Mol Imaging. 2015. PMID: 25267348 Free PMC article.
Whole-genome sequencing identifies patient-specific DNA minimal residual disease markers in neuroblastoma.
van Wezel EM, Zwijnenburg D, Zappeij-Kannegieter L, Bus E, van Noesel MM, Molenaar JJ, Versteeg R, Fiocco M, Caron HN, van der Schoot CE, Koster J, Tytgat GA. van Wezel EM, et al. Among authors: van noesel mm, van der schoot ce. J Mol Diagn. 2015 Jan;17(1):43-52. doi: 10.1016/j.jmoldx.2014.09.005. Epub 2014 Oct 24. J Mol Diagn. 2015. PMID: 25445214 Free article.
138 results